EA201892708A1 - PHARMACEUTICAL COMPOSITION CONTAINING DIMETHYLFUMARATE FOR ADMINISTRATION IN A LOW DAILY DOSE - Google Patents

PHARMACEUTICAL COMPOSITION CONTAINING DIMETHYLFUMARATE FOR ADMINISTRATION IN A LOW DAILY DOSE

Info

Publication number
EA201892708A1
EA201892708A1 EA201892708A EA201892708A EA201892708A1 EA 201892708 A1 EA201892708 A1 EA 201892708A1 EA 201892708 A EA201892708 A EA 201892708A EA 201892708 A EA201892708 A EA 201892708A EA 201892708 A1 EA201892708 A1 EA 201892708A1
Authority
EA
Eurasian Patent Office
Prior art keywords
pharmaceutical composition
daily dose
administration
composition containing
low daily
Prior art date
Application number
EA201892708A
Other languages
Russian (ru)
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Publication of EA201892708A1 publication Critical patent/EA201892708A1/en

Links

Landscapes

  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

Настоящее изобретение относится к фармацевтическим композициям, содержащим диметилфумарат (ДМФ). Более конкретно, настоящее изобретение относится к фармацевтической композиции для перорального применения при лечении псориаза путём введения низкой суточной дозы диметилфумарата в диапазоне 375 мг ± 5%, причём указанный фармацевтический состав находится в форме таблетки с разлагаемой матрицей.The present invention relates to pharmaceutical compositions containing dimethyl fumarate (DMF). More specifically, the present invention relates to a pharmaceutical composition for oral administration in the treatment of psoriasis by administering a low daily dose of dimethyl fumarate in the range of 375 mg ± 5%, said pharmaceutical composition being in the form of a tablet with a degradable matrix.

EA201892708A 2014-08-11 2014-08-26 PHARMACEUTICAL COMPOSITION CONTAINING DIMETHYLFUMARATE FOR ADMINISTRATION IN A LOW DAILY DOSE EA201892708A1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US201462035898P 2014-08-11 2014-08-11

Publications (1)

Publication Number Publication Date
EA201892708A1 true EA201892708A1 (en) 2019-10-31

Family

ID=68319009

Family Applications (2)

Application Number Title Priority Date Filing Date
EA201892709A EA201892709A1 (en) 2014-08-11 2014-08-26 PHARMACEUTICAL COMPOSITION CONTAINING DIMETHYLFUMARATE FOR ADMINISTRATION IN A LOW DAILY DOSE
EA201892708A EA201892708A1 (en) 2014-08-11 2014-08-26 PHARMACEUTICAL COMPOSITION CONTAINING DIMETHYLFUMARATE FOR ADMINISTRATION IN A LOW DAILY DOSE

Family Applications Before (1)

Application Number Title Priority Date Filing Date
EA201892709A EA201892709A1 (en) 2014-08-11 2014-08-26 PHARMACEUTICAL COMPOSITION CONTAINING DIMETHYLFUMARATE FOR ADMINISTRATION IN A LOW DAILY DOSE

Country Status (1)

Country Link
EA (2) EA201892709A1 (en)

Also Published As

Publication number Publication date
EA201892709A1 (en) 2019-10-31

Similar Documents

Publication Publication Date Title
EA201690102A1 (en) PHARMACEUTICAL COMPOSITION CONTAINING DIMETHYLFUMATE FOR INTRODUCTION TO LOW DAILY DOSE
NZ742220A (en) Pharmaceutical compositions comprising meloxicam
CY1116695T1 (en) COMPOSITION CONTAINING SUPER-MICRONOMINATED PALMITOYL-ETHANOLAMIDE
MX2016016666A (en) Boronic acid derivatives and therapeutic uses thereof.
MX2016015093A (en) Boronic acid derivatives and therapeutic uses thereof.
PE20150092A1 (en) PHARMACEUTICAL COMPOSITIONS CONTAINING DIMETHYL FUMARATE
AR101674A1 (en) USE OF A TRICYCLIC COMPOUND CONTAINING NITROGEN
EA201790726A1 (en) PHARMACEUTICAL COMPOSITION FOR THE TREATMENT OF ULCERAL COLITIS
ECSP16084317A (en) PHARMACEUTICAL FORMULATIONS, PREPARATION PROCESSES AND METHODS OF USE
PH12018500377A1 (en) Novel annelated benzamides
PH12018500378A1 (en) Novel annelated phenoxyacetamides
GB2523707A (en) Novel pharmaceutical formulations and their use in the treatment of periodontal disease
MX367926B (en) Pharmaceutical composition for a sustained release of lanreotide.
ZA202006377B (en) Boronic acid derivatives and therapeutic uses thereof
WO2015009731A3 (en) Azacyclic constrained analogs of fty720
EA201890929A1 (en) LOW DOSES OF DIPYRIDAMOL COMPOSITIONS FOR ORAL ADMINISTRATION AND THEIR USE
EA201892708A1 (en) PHARMACEUTICAL COMPOSITION CONTAINING DIMETHYLFUMARATE FOR ADMINISTRATION IN A LOW DAILY DOSE
MX2016006375A (en) A combination of dosage units for use in the treatment of pre-term labour condition.
EA201592261A1 (en) PHARMACEUTICAL COMPOSITIONS, INCLUDING AGOMELATIN IN THE FORM OF HOMELATIN CRYSTALS WITH ORGANIC ACID
MX2013006332A (en) Oral pharmaceutical compositions for use in dyslipidemias.
MD4458C1 (en) Use of Polybiolin drug in patients with liver cirrhosis
CL2018001236A1 (en) Pharmaceutical composition containing, as active ingredient, derivative of 7-azaindolin-2-one or pharmaceutically acceptable salt thereof.
GR1008804B (en) Medical compositions containing hyaluronic acid or salts thereof, amino acids, vitamins, non-organic salts and other components
JP2017514820A5 (en)
IN2014MU01179A (en)